Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 27:7:779.
doi: 10.3389/fpsyg.2016.00779. eCollection 2016.

"It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England

Affiliations

"It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England

Elisabeth J Vargo et al. Front Psychol. .

Abstract

The non-medical use of prescription medication for the pursuit of increasing cognitive and intellectual capacities (defined neuroenhancement) has received growing attention from the scientific community and policymakers alike. To date, limited qualitative data exist exploring the nature of the phenomenon, especially as a potentially emerging trend among university students in England. Existing American literature suggests that students believe that neuroenhancement helps the individual to maximize his/her time, consenting a suitable balance between work and leisure. Students' motivation to experiment with neuroenhancement appears to be more in line with a need to regulate emotions surrounding study/work settings than to actually improve cognitive abilities beyond normal levels. This study aimed to qualitatively explore representations, motivations, beliefs, and consumption styles of a cohort of university student users residing in England. Through snowball sampling, 13 informants were contacted and interviewed regarding their experience with neuroenhancers. Narrations were analyzed and interpreted using qualitative analysis software and Grounded Theory methodology. Participants belonged to a broad variety of university courses and were predominantly habitual consumers of modafinil. Neuroenhancers were acquired either through friends or via the Internet. Motivations regarded the need to "catch up" and be on par with high achieving students. The entire cohort had previously experimented with other psychotropic substances. Synthetic compounds in particular were believed to be "gateway" drugs to using neuroenhancers. Experimentation with neuroenhancement can be seen as a self-governing strategy aimed at achieving continued focused productivity. Participants acknowledged sustainable benefits in neuroenhancement as it optimized work performance. The majority of the cohort also contemplated the possibility of using these drugs in the future once they entered the workforce. Neuroenhancing drug users expressed "situated morality," differentiating between using these substances for assessments (exams) or during revisions, finding only the former as an immoral conduct. In the present scenario, it appears that neuroenhancement is practiced by small numbers of students. Nonetheless, the instrumental views of psychotropic substances held by many young adults and the globalization of these practices make the normalization of neuroenhancement a plausible possibility of the future.

Keywords: cognitive enhancing drugs; drug instrumentalization; grounded theory; normalization; students.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Sociogram of the study population. Numbers represent the order of recruitment.
FIGURE 2
FIGURE 2
Conceptual map depicting the sample’s storyline. Nodes represent the most relevant codes according to groundedness and centrality in the interpretative process. Links represent relationships between codes.

Similar articles

Cited by

References

    1. Advisory Council on the Misuse of Drugs [ACMD] (2015). Drug Penalties. London: Advisory Council on the Misuse of Drugs; Available at: https://www.gov.uk/penalties-drug-possession-dealing
    1. Atkinson R. (1998). The Life Story Interview. Thousand Oaks, CA: Sage.
    1. Banjo O. C., Nadler R., Reiner P. B. (2010). Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount. PLoS ONE 5:e14322 10.1371/journal.pone.0014322 - DOI - PMC - PubMed
    1. Bell S., Partridge B., Lucke J., Hall W. (2013). Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics 6 197–205. 10.1007/s12152-012-9153-9 - DOI
    1. Benanti P. (2010). Neuroenhancement in young people: cultural need or medical technology? AJOB Neurosci. 1 27–29. 10.1080/21507740903523210 - DOI

LinkOut - more resources